Abstract #2764

MRI-guided prostate biopsies at 3 T – clinical experience with a navigation option

Harald Busse¹, Josephin Otto¹, Alexander Schaudinn¹, Nicolas Linder¹, Simone Mucha¹, Nikita Garnov¹, Minh Do², Roman Ganzer², Jens-Uwe Stolzenburg², Lars-Christian Horn³, Thomas Kahn¹, and Michael Moche¹

¹Diagnostic and Interventional Radiology Department, Leipzig University Hospital, Leipzig, Germany, ²Urology Department, Leipzig University Hospital, Leipzig, Germany, ³Institute of Pathology, University of Leipzig, Leipzig, Germany

Multiparametric MRI has been shown to improve the detection and localization of prostate cancer and is therefore ideally suited for targeting as well. While biopsy guidance in an MRI system typically requires more efforts and time (30‑120 min) than under ultrasound imaging, MRI provides unparalleled contrast of the prostate substructures. Diagnostic detection rates show large variability between patient groups and sites (about 10-60%). With a custom-made navigation option for a commercial device, any intraprocedural MRI data can be used for stereotactic real-time biopsy targeting. This work presents navigation features, indications and clinical biopsy results for a total of 75 patients.

This abstract and the presentation materials are available to members only; a login is required.

Join Here